Drugs / NY-ESO-1
NY-ESO-1
also known as
Eso-1 · L antigen family member 2 · Lage-2 · NY-ESO-1 Protein Vaccine · Ny-eso-1(157-170)
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT01810016 | Jan 2014 → May 2016 | metastatic melanoma | Ludwig Institute for Cancer Research | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT01176461 | Aug 2010 → Dec 2016 | cutaneous melanoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
| Phase 1 | NCT00299728 | Mar → Oct 2006 | neoplasm | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
| Phase 1 | NCT00142454 | Aug 2005 → Apr 2006 | melanoma | Ludwig Institute for Cancer Research | Completed | No outcome recorded |
| Phase 1/23 trials | ||||||
| Phase 1/2 | NCT01584115 | Jul 2012 → Jul 2013 | lung cancer, melanoma, ovarian cancer | Instituto de Investigação em Imunologia | Unknown | No outcome recorded |
| Phase 1/2 | NCT01079741 | Sep 2010 → Mar 2013 | melanoma | Nina Bhardwaj | Completed | No outcome recorded |
| Phase 1/2 | NCT01308294 | Jun 2010 → Apr 2014 | melanoma | Centre Hospitalier Universitaire Vaudois | Terminated | No outcome recorded Stop: Enrollment |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00090493 | Jun 2004 → Jul 2007 | plasma cell myeloma | University of Arkansas | Completed | No outcome recorded |
Press releases naming this drug 7 releases
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NY-ESO-1 | “syringe 1 containing NA-17, MAGE-3.A2 and NY-ESO-1 peptides with IMP321/LAG3 ± Montanide” NCT01308294 ↗ |
| Known as | Eso-1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594483 ↗ |
| Known as | L antigen family member 2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594483 ↗ |
| Known as | Lage-2 | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594483 ↗ |
| Known as | NY-ESO-1 Protein Vaccine | “Biological: NY-ESO-1 Protein Vaccine” NCT01810016 ↗ |
| Known as | Ny-eso-1(157-170) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594483 ↗ |
| Modality | Protein / enzyme biologic | “NY-ESO-1 recombinant protein mixed with CpG 7909 and Montanide ISA-51 VG” NCT00299728 ↗ |
| Route | Subcutaneous | “The vaccinations was to be administered subcutaneously every 3 weeks for 4 doses.” NCT00299728 ↗ |